Dalla Volta A, Valcamonico F, Zivi A, Procopio G, et al. Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide. Eur Urol 2024 May 20:S0302-2838(24)02347-9. doi: 10.1016/j.eururo.2024.
PMID: 38772788